Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.

Cancer cell | 2010

Oncogene addiction is thought to occur cell autonomously. Immune effectors are implicated in the initiation and restraint of tumorigenesis, but their role in oncogene inactivation-mediated tumor regression is unclear. Here, we show that an intact immune system, specifically CD4(+) T cells, is required for the induction of cellular senescence, shutdown of angiogenesis, and chemokine expression resulting in sustained tumor regression upon inactivation of the MYC or BCR-ABL oncogenes in mouse models of T cell acute lymphoblastic lymphoma and pro-B cell leukemia, respectively. Moreover, immune effectors knocked out for thrombospondins failed to induce sustained tumor regression. Hence, CD4(+) T cells are required for the remodeling of the tumor microenvironment through the expression of chemokines, such as thrombospondins, in order to elicit oncogene addiction.

Pubmed ID: 21035406 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: CA 112973
  • Agency: NCI NIH HHS, United States
    Id: R01 CA105102-06
  • Agency: NCI NIH HHS, United States
    Id: U56 CA112973
  • Agency: NCI NIH HHS, United States
    Id: P01 CA034233
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: NCI NIH HHS, United States
    Id: P50 CA114747-050002
  • Agency: NCI NIH HHS, United States
    Id: R01 CA089305
  • Agency: NCI NIH HHS, United States
    Id: CA 114747
  • Agency: NCI NIH HHS, United States
    Id: R01 CA105102
  • Agency: NCI NIH HHS, United States
    Id: K23 CA140722
  • Agency: NCI NIH HHS, United States
    Id: R01 CA118374
  • Agency: NCI NIH HHS, United States
    Id: R01 CA 118374
  • Agency: NCI NIH HHS, United States
    Id: R01 CA089305-10
  • Agency: NCI NIH HHS, United States
    Id: P01 CA034233-260034
  • Agency: NCI NIH HHS, United States
    Id: P50 CA114747

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Living Image software (tool)

RRID:SCR_014247

In vivo imaging software which facilitates workflow for in vivo optical, X-ray and microCT image acquisition, analysis and data organization.

View all literature mentions